Intraindividual genome expression analysis reveals a specific molecular signature of psoriasis and eczema

Science Translational Medicine

Volumn 6, Issue 244, 2014, Pages

  Quaranta, Maria ^a   Knapp, Bettina ^b   Garzorz, Natalie ^a   Mattii, Martina ^a   Pullabhatla, Venu ^c   Pennino, Davide ^a   Andres, Christian ^a   Traidl Hoffmann, Claudia ^a   Cavani, Andrea ^d   Theis, Fabian J ^a,b   Ring, Johannes ^a   Schmidt Weber, Carsten B ^a   Eyerich, Stefanie ^a   Eyerich, Kilian ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c GUY S HOSPITAL   (United Kingdom)

^d LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CUTANEOUS T CELL ATTRACTING CHEMOKINE; CYTOKINE; GUANINE DEAMINASE; HAPTOCORRIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 36; INTERLEUKIN 6; SCLEROSTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ATOPIC DERMATITIS; C TYPE LECTIN FAMILY MEMBER 4 GENE; CHEMOKINE (C-C MOTIF) LIGAND 27 GENE; CLASSIFIER; CLINICAL ARTICLE; COMORBIDITY; CONTACT DERMATITIS; CONTROLLED STUDY; DIFFERENTIATION; DOWN REGULATION; ECZEMA; EPIDERMIS; FEMALE; GENE; GENE EXPRESSION; GENE ONTOLOGY; GLUCOSE METABOLISM; GUANINE DEAMINASE GENE; HUMAN; HUMAN TISSUE; INDUCIBLE NITRIC OXIDE SYNTHASE 2 GENE; INTERLEUKIN 13 GENE; INTERLEUKIN 36A GENE; INTERLEUKIN 36G GENE; KALLIKREIN RELATED PEPTIDASE 13 GENE; LIPID METABOLISM; MALE; NEURONAL PENTRAXIN 1 GENE; PATHOGENESIS; PHOSPHOLIPASE A2 GROUP IVG GENE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PSORIASIS; PSORIASIS VULGARIS; RH FAMILY C GLYCOPROTEIN GENE; SCLEROSTIN GENE; SERINE TRANSMEMBRANE PROTEASE 11D GENE; SIGNAL TRANSDUCTION; TH17 CELL; TH2 CELL; TRANSCOBALAMIN 1 GENE; TRANSGLUTAMINASE 1 GENE; UPREGULATION; COHORT ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; MIDDLE AGED; PATHOLOGY;

ADULT; COHORT STUDIES; ECZEMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; PSORIASIS; SIGNAL TRANSDUCTION;

EID: 84904480206     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3008946     Document Type: Article

References (50)

1. T. Bieber, Atopic dermatitis. N. Engl. J. Med. 358, 1483-1494 (2008).
2. F. O. Nestle, D. H. Kaplan, J. Barker, Psoriasis. N. Engl. J. Med. 361, 496-509 (2009).
3. K. Eyerich, N. Novak, Immunology of atopic eczema: Overcoming the Th1/Th2 paradigm. Allergy 68, 974-982 (2013).
4. E. Guttman-Yassky, K. E. Nograles, J. G. Krueger, Contrasting pathogenesis of atopic dermatitis and psoriasis - Part II: Immune cell subsets and therapeutic concepts. J. Allergy Clin. Immunol. 127, 1420-1432 (2011).
5. M. Suárez-Fariñas, S. J. Tintle, A. Shemer, A. Chiricozzi, K. Nograles, I. Cardinale, S. Duan, A. M. Bowcock, J. G. Krueger, E. Guttman-Yassky, Nonlesional atopic dermatitis skin is characterized by broad terminal differentiation defects and variable immune abnormalities. J. Allergy Clin. Immunol. 127, 954-964.e4 (2011).
6. S. Tian, J. G. Krueger, K. Li, A. Jabbari, C. Brodmerkel, M. A. Lowes, M. Suárez-Fariñas, Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease. PLOS One 7, e44274 (2012).
7. M. Suárez-Fariñas, K. Li, J. Fuentes-Duculan, K. Hayden, C. Brodmerkel, J. G. Krueger, Expanding the psoriasis disease profile: Interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J. Invest. Dermatol. 132, 2552-2564 (2012).
8. +-mediated inflammation and distinguishes this disease from atopic dermatitis and psoriasis. J. Invest. Dermatol. 128, 67-78 (2008).
9. I. Nomura, B. Gao, M. Boguniewicz, M. A. Darst, J. B. Travers, D. Y. Leung, Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: A gene microarray analysis. J. Allergy Clin. Immunol. 112, 1195-1202 (2003).
10. G. J. de Jongh, P. L. Zeeuwen, M. Kucharekova, R. Pfundt, P. G. van der Valk, W. Blokx, A. Dogan, P. S. Hiemstra, P. C. van de Kerkhof, J. Schalkwijk, High expression levels of keratinocyte antimicrobial proteins in psoriasis compared with atopic dermatitis. J. Invest. Dermatol. 125, 1163-1173 (2005).
11. S. Eyerich, A. T. Onken, S. Weidinger, A. Franke, F. Nasorri, D. Pennino, M. Grosber, F. Pfab, C. B. Schmidt-Weber, M. Mempel, R. Hein, J. Ring, A. Cavani, K. Eyerich, Mutual antagonism of T cells causing psoriasis and atopic eczema. N. Engl. J. Med. 365, 231-238 (2011).
12. E. Guttman-Yassky, M. Suárez-Fariñas, A. Chiricozzi, K. E. Nograles, A. Shemer, J. Fuentes-Duculan, I. Cardinale, P. Lin, R. Bergman, A. M. Bowcock, J. G. Krueger, Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J. Allergy Clin. Immunol. 124, 1235-1244.e58 (2009).
13. E. Guttman-Yassky, M. A. Lowes, J. Fuentes-Duculan, L. C. Zaba, I. Cardinale, K. E. Nograles, A. Khatcherian, I. Novitskaya, J. A. Carucci, R. Bergman, J. G. Krueger, Low expression of the IL-23/Th17 pathway in atopic dermatitis compared to psoriasis. J. Immunol. 181, 7420-7427 (2008).
14. S. G. Johansson, T. Bieber, R. Dahl, P. S. Friedmann, B. Q. Lanier, R. F. Lockey, C. Motala, J. A. Ortega Martell, T. A. Platts-Mills, J. Ring, F. Thien, P. Van Cauwenberge, H. C. Williams, Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 113, 832-836 (2004).
15. S. F. Martin, P. R. Esser, F. C. Weber, T. Jakob, M. A. Freudenberg, M. Schmidt, M. Goebeler, Mechanisms of chemical-induced innate immunity in allergic contact dermatitis. Allergy 66, 1152-1163 (2011).
16. K. Eyerich, R. Böckelmann, A. J. Pommer, S. Foerster, H. Hofmeister, J. Huss-Marp, A. Cavani, H. Behrendt, J. Ring, H. Gollnick, B. Bonnekoh, C. Traidl-Hoffmann, Comparative in situ topoproteome analysis reveals differences in patch test-induced eczema: Cytotoxicity-dominated nickel versus pleiotrope pollen reaction. Exp. Dermatol. 19, 511-517 (2010).
17. K. Eyerich, J. Huss-Marp, U. Darsow, A. Wollenberg, S. Foerster, J. Ring, H. Behrendt, C. Traidl-Hoffmann, Pollen grains induce a rapid and biphasic eczematous immune response in atopic eczema patients. Int. Arch. Allergy Immunol. 145, 213-223 (2008).
18. H. Iizuka, H. Takahashi, M. Honma, A. Ishida-Yamamoto, Unique keratinization process in psoriasis: Late differentiation markers are abolished because of the premature cell death. J. Dermatol. 31, 271-276 (2004).
19. R. de Cid, E. Riveira-Munoz, P. L. Zeeuwen, J. Robarge, W. Liao, E. N. Dannhauser, E. Giardina, P. E. Stuart, R. Nair, C. Helms, G. Escaramís, E. Ballana, G. Martín-Ezquerra, M. den Heijer, M. Kamsteeg, I. Joosten, E. E. Eichler, C. Lázaro, R. M. Pujol, L. Armengol, G. Abecasis, J. T. Elder, G. Novelli, J. A. Armour, P. Y. Kwok, A. Bowcock, J. Schalkwijk, X. Estivill, Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 41, 211-215 (2009).
20. J. G. Bergboer, P. L. Zeeuwen, A. D. Irvine, S. Weidinger, E. Giardina, G. Novelli, M. Den Heijer, E. Rodriguez, T. Illig, E. Riveira-Munoz, L. E. Campbell, J. Tyson, E. N. Dannhauser, G. M. O'Regan, E. Galli, N. Klopp, G.H. Koppelman, N. Novak, X. Estivill, W. H.McLean, D. S. Postma, J. A. Armour, J. Schalkwijk, Deletion of late cornified envelope 3B and 3C genes is not associated with atopic dermatitis. J. Invest. Dermatol. 130, 2057-2061 (2010).
21. A. D. Irvine, W. H. McLean, D. Y. Leung, Filaggrin mutations associated with skin and allergic diseases. N. Engl. J. Med. 365, 1315-1327 (2011).
22. M. Takaishi, T. Makino, M. Morohashi, N. H. Huh, Identification of human hornerin and its expression in regenerating and psoriatic skin. J. Biol. Chem. 280, 4696-4703 (2005).
23. S. M. Sa, P. A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, I. Kasman, J. Winer, Z. Modrusan, D. M. Danilenko, W. Ouyang, The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J. Immunol. 178, 2229-2240 (2007).
24. J. E. Towne, J. E. Sims, IL-36 in psoriasis. Curr. Opin. Pharmacol. 12, 486-490 (2012).
25. R. Caruso, E. Botti, M. Sarra, M. Esposito, C. Stolfi, L. Diluvio, M. L. Giustizieri, V. Pacciani, A. Mazzotta, E. Campione, T. T. Macdonald, S. Chimenti, F. Pallone, A. Costanzo, G. Monteleone, Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat. Med. 15, 1013-1015 (2009).
26. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445, 648-651 (2007).
27. M. D. Howell, B. E. Kim, P. Gao, A. V. Grant, M. Boguniewicz, A. DeBenedetto, L. Schneider, L. A. Beck, K. C. Barnes, D. Y. Leung, Cytokine modulation of atopic dermatitis filaggrin skin expression. J. Allergy Clin. Immunol. 124, R7-R12 (2009).
28. B. E. Kim, D. Y. Leung, M. Boguniewicz, M. D. Howell, Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin. Immunol. 126, 332-337 (2008).
29. K. Eyerich, D. Pennino, C. Scarponi, S. Foerster, F. Nasorri, H. Behrendt, J. Ring, C. Traidl-Hoffmann, C. Albanesi, A. Cavani, IL-17 in atopic eczema: Linking allergen-specific adaptive and microbial-triggered innate immune response. J. Allergy Clin. Immunol. 123, 59-66.e4 (2009).
30. C. Albanesi, H. R. Fairchild, S. Madonna, C. Scarponi, O. De Pità, D. Y. Leung, M. D. Howell, IL-4 and IL-13 negatively regulate TNF-α- and IFN-γ-induced β-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J. Immunol. 179, 984-992 (2007).
31. G. Sotiropoulou, G. Pampalakis, Kallikrein-related peptidases: Bridges between immune functions and extracellular matrix degradation. Biol. Chem. 391, 321-331 (2010).
32. P. Y. Ong, T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, D. Y. Leung, Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347, 1151-1160 (2002).
33. V. Kopfnagel, J. Harder, T. Werfel, Expression of antimicrobial peptides in atopic dermatitis and possible immunoregulatory functions. Curr. Opin. Allergy Clin. Immunol. 13, 531-536 (2013).
34. A. A. Navarini, L. E. French, G. F. Hofbauer, Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J. Allergy Clin. Immunol. 128, 1128-1130 (2011).
35. H. D. de Koning, M. Kamsteeg, D. Rodijk-Olthuis, I. M. van Vlijmen-Willems, P. E. van Erp, J. Schalkwijk, P. L. Zeeuwen, Epidermal expression of host response genes upon skin barrier disruption in normal skin and uninvolved skin of psoriasis and atopic dermatitis patients. J. Invest. Dermatol. 131, 263-266 (2011).
36. J. M. Petrash, All in the family: Aldose reductase and closely related aldo-keto reductases. Cell. Mol. Life Sci. 61, 737-749 (2004).
37. J. K. Wolford, Y. L. Konheim, P. B. Colligan, C. Bogardus, Association of a F479L variant in the cytosolic phospholipase A2 gene (PLA2G4A) with decreased glucose turnover and oxidation rates in Pima Indians. Mol. Genet. Metab. 79, 61-66 (2003).
38. C. R. Parish, C. Freeman, A. F. Ziolkowski, Y. Q. He, E. L. Sutcliffe, A. Zafar, S. Rao, C. J. Simeonovic, Unexpected new roles for heparanase in type 1 diabetes and immune gene regulation. Matrix Biol. 32, 228-233 (2013).
39. J. L. Evans, I. D. Goldfine, Aging and insulin resistance: Just say iNOS. Diabetes 62, 346-348 (2013).
40. D. C. Patel, C. Albrecht, D. Pavitt, V. Paul, C. Pourreyron, S. P. Newman, I. F. Godsland, J. Valabhji, D. G. Johnston, Type 2 diabetes is associated with reduced ATP-binding cassette transporter A1 gene expression, protein and function. PLOS One 6, e22142 (2011).
41. C. García-Jiménez, J. M. García-Martínez, A. Chocarro-Calvo, A. De la Vieja, A new link between diabetes and cancer: Enhanced Wnt/β-catenin signaling by high glucose. J. Mol. Endocrinol. 52, R51-R66 (2013).
42. I. Augustin, J. Gross, D. Baumann, C. Korn, G. Kerr, T. Grigoryan, C. Mauch, W. Birchmeier, M. Boutros, Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis. J. Exp. Med. 210, 1761-1777 (2013).
43. P. Gisondi, G. Tessari, A. Conti, S. Piaserico, S. Schianchi, A. Peserico, A. Giannetti, G. Girolomoni, Prevalence of metabolic syndrome in patients with psoriasis: A hospital-based case-control study. Br. J. Dermatol. 157, 68-73 (2007).
44. M. Malerba, P. Gisondi, A. Radaeli, G. Girolomoni, Psoriasis and risk of myocardial infarction. JAMA 297, 361; author reply 362-363 (2007).
45. J. R. Kanwar, R. K. Kanwar, H. Burrow, S. Baratchi, Recent advances on the roles of NO in cancer and chronic inflammatory disorders. Curr. Med. Chem. 16, 2373-2394 (2009).
46. H. Mühl, M. Bachmann, J. Pfeilschifter, Inducible NO synthase and antibacterial host defence in times of Th17/Th22/T22 immunity. Cell. Microbiol. 13, 340-348 (2011).
47. M. Mildner, M. Prior, M. Gschwandtner, C. Schuster, E. Tschachler, A. Elbe-Bürger, Epidermal CCL27 expression is regulated during skin development and keratinocyte differentiation. J. Invest. Dermatol. 134, 855-858 (2014).
48. Y. Benjamini, Y. Hochberg, Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Statist. Soc. B 57, 289-300 (1995).
49. W. Stacklies, H. Redestig, M. Scholz, D. Walther, J. Selbig, pcaMethods - A Bioconductor package providing PCA methods for incomplete data. Bioinformatics 23, 1164-1167 (2007).
50. A. Alexa, J. Rahnenführer, T. Lengauer, Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22, 1600-1607 (2006).